https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39822 0.8), and only 2 studies were able to externally validate their developed model. In general, models that performed well used large patient numbers, were tested on similar demographics, and used either nonlinear input transformations or a completely nonlinear model. Conclusion: Some models do show promise; however, there remains the question of whether the reported predictive success can continue to be replicated. Furthermore, clinical applicability and interpretation of predictive tools should be considered during development.]]> Tue 26 Jul 2022 11:57:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51580 1 month with <7 days symptoms, chronic >1 month with >7 days symptoms) classifications. Results: DAIR success was 45% (85/189) and was highest in early PJIs defined according to the Coventry (adjusted odds ratio [aOR] = 3.9, P =.01), the International Consensus Meeting (aOR = 3.1, P =.01), and the Auckland classifications (aOR = 2.6, P =.01). Success was lower in both hematogenous (aOR = 0.4, P =.03) and chronic infections (aOR = 0.1, P =.003). Conclusion: Time since primary TKA is an important predictor of DAIR success. Success was highest in infections occurring <1 month of the primary TKA and progressively decreased as time since the primary TKA increased.]]> Mon 11 Sep 2023 14:30:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42156 Fri 19 Aug 2022 09:01:13 AEST ]]>